BENJAMIN GENTRY: Open Payments
NPI 1811246317 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 30 payments from 13 companies in 2025. Trend: 2023 $1,038 · 2024 $582 · 2025 $718
Food & beverage: $717Education: $2
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $114 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Amgen Inc. | 3 | $80 |
| Aurinia Pharma U.S., Inc. | 4 | $73 |
| Calliditas Therapeutics US Inc. | 3 | $67 |
| Mallinckrodt Hospital Products Inc. | 3 | $64 |
| Travere Therapeutics, Inc. | 4 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| AKEBIA THERAPEUTICS INC | 1 | $29 |
Products named: Ozempic, JYNARQUE, LUPKYNIS, TARPEYO, TAVNEOS, Kerendia, JARDIANCE, TERLIVAZ.
Industry payments across GA — which companies pay providers there.
